Intermittent preventive treatment of malaria in pregnancy: At the crossroads of public health policy

Tropical Medicine and International Health

Volumn 16, Issue 7, 2011, Pages 774-785

  Chico, R Matthew ^a   Chandramohan, Daniel ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa south of the Sahara; Antenatal care; Intermittent preventive treatment of malaria in pregnancy; Malaria; Pregnancy; Sexually transmitted infections

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; DARUNAVIR PLUS RITONAVIR; ETRAVIRINE; MEFLOQUINE; NELFINAVIR; PIPERAQUINE; PYRIMETHAMINE PLUS SULFADOXINE;

DISEASE CONTROL; DISEASE TRANSMISSION; DISEASE TREATMENT; DRUG; DRUG RESISTANCE; EPIDEMIOLOGY; HEALTH POLICY; MALARIA; PREGNANCY; PUBLIC HEALTH; REPRODUCTIVE DISORDER; REPRODUCTIVE HEALTH; SEXUALLY TRANSMITTED DISEASE;

DRUG BLOOD LEVEL; GASTROINTESTINAL DISEASE; HEALTH CARE POLICY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MALARIA; PARASITEMIA; POINT OF CARE TESTING; PREGNANCY; PRENATAL CARE; PUBLIC HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYSTEMATIC REVIEW;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIMALARIALS; AZITHROMYCIN; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA; MEFLOQUINE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL CARE; PUBLIC HEALTH; PYRIMETHAMINE; SEXUALLY TRANSMITTED DISEASES; SULFADOXINE; TREATMENT OUTCOME;

SUB-SAHARAN AFRICA;

EID: 79958830015     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02765.x     Document Type: Review

References (94)

1. Alary M, Baganizi E, Guedeme A et al. (1998) Evaluation of clinical algorithms for the diagnosis of gonococcal and chlamydial infections among men with urethral discharge or dysuria and women with vaginal discharge in Benin. Sexually Transmitted Infections 74(Suppl 1), S44-S49.
2. Amsden GW, Nafziger AN, Foulds G & Cabelus LJ (2000) A study of the pharmacokinetics of azithromycin and nelfinavir when coadministered in healthy volunteers. Journal of Clinical Pharmacology 40, 1522-1527.
3. Ashworth A (1998) Effects of intrauterine growth retardation on mortality and morbidity in infants and young children. European Journal of Clinical Nutrition 52 (Suppl 1), S34-S41; discussion S41-2.
4. Barker DJ (2004) The developmental origins of adult disease. Journal of the American College of Nutrition 23, 588S-595S.
5. Bray PG, Boulter MK, Ritchie GY, Howells RE & Ward SA (1994) Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum. Molecular and Biochemical Parasitology 63, 87-94.
6. Briand V, Bottero J, Noel H et al. (2009) Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. Journal of Infectious Diseases 200, 991-1001.
7. Chico RM (2010) Burden of infections during pregnancy in Sub-Saharan Africa. 59th Annual Meeting of the American Society of Tropical Medicine and Hygiene. London School of Hygiene and Tropical Medicine, Atlanta, GA, USA.
8. Chico RM, Pittrof R, Greenwood B & Chandramohan D (2008) Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malaria Journal 7, 255.
9. Dahl EL & Rosenthal PJ (2008) Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends in Parasitology 24, 279-284.
10. Daly CC, Wangel AM, Hoffman IF et al. (1998) Validation of the WHO diagnostic algorithm and development of an alternative scoring system for the management of women presenting with vaginal discharge in Malawi. Sexually Transmitted Infections 74, S50-S58.
11. Davis TM, Hung TY, Sim IK, Karunajeewa HA & Ilett KF (2005) Piperaquine: a resurgent antimalarial drug. Drugs 65, 75-87.
12. De Roode JC, Helinski ME, Anwar MA & Read AF (2005) Dynamics of multiple infection and within-host competition in genetically diverse malaria infections. The American Naturalist 166, 531-542.
13. Diaz T, Almeida MG, Georg I, Maia SC, De Souza RV & Markowitz LE (2004) Evaluation of the determine rapid syphilis TP assay using sera. Clinical and Diagnostic Laboratory Immunology 11, 98-101.
14. Djimde A, Doumbo OK, Cortese JF et al. (2001) A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine 344, 257-263.
15. Dooley KE, Flexner C & Andrade AS (2008) Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. Journal of Infectious Diseases 198, 948-961.
16. Dunne MW, Singh N, Shukla M et al. (2005) A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. Journal of Infectious Diseases 191, 1582-1588.
17. Eriksson JG, Forsen T, Tuomilehto J, Osmond C & Barker DJ (2001) Early growth and coronary heart disease in later life: longitudinal study. BMJ 322, 949-953.
18. Fried MDP (1998) Maternal malaria and parasite adhesion. Journal of Molecular Medicine 76, 162-171.
19. Garner P & Gulmezoglu AM (2006) Drugs for preventing malaria in pregnant women. The Cochrane Database of Systematic Reviews 4, CD000169.
20. Gesase S, Gosling RD, Hashim R et al. (2009) High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One 4, e4569.
21. Godfrey KM & Barker DJ (2000) Fetal nutrition and adult disease. American Journal of Clinical Nutrition 71, 1344S-1352S.
22. Gray RH, Wabwire-Mangen F, Kigozi G et al. (2001) Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. American Journal of Obstetrics and Gynecology 185, 1209-1217.
23. Handsfield HH, Dalu ZA, Martin DH, Douglas JM Jr, Mccarty JM & Schlossberg D (1994) Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sexually Transmitted Diseases 21, 107-111.
24. Harries AD, Zachariah R, Van Oosterhout JJ et al. (2010) Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. The Lancet Infectious Diseases 10, 60-65.
25. Harrington WE, Mutabingwa TK, Muehlenbachs A et al. (2009) Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proceedings of the National Academy of Sciences of the United States of America 106, 9027-9032.
26. Jacquerioz FA & Croft AM (2009) Drugs for preventing malaria in travellers. The Cochrane Database of Systematic Reviews 4, CD006491.
27. Jaffar S, Amuron B, Foster S et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374, 2080-2089.
28. Kalilani L, Mofolo I, Chaponda M et al. (2007) A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. PLoS One 2, e1166.
29. Kapito-Tembo A, Meshnick SR, Van Hensbroek MB, Phiri K, Fitzgerald M & Mwapasa V (2011) Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi. Journal of Infectious Diseases 203, 464-472.
30. Kaul R, Kimani J, Nagelkerke NJ et al. (2004) Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291, 2555-2562.
31. Khaliq Y, Gallicano K, Tisdale C, Carignan G, Cooper C & Mccarthy A (2001) Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers. British Journal of Clinical Pharmacology 51, 591-600.
32. Kiddugavu MG, Kiwanuka N, Wawer MJ et al. (2005) Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sexually Transmitted Diseases 32, 1-6.
33. Kinney MV, Kerber KJ, Black RE et al. (2010) Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Medicine 7, e1000294.
34. Kramer MS (1987) Determinants of low birthweight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 65, 663-737.
35. Kublin JG, Cortese JF, Njunju EM et al. (2003) Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. Journal of Infectious Diseases 187, 1870-1875.
36. Laufer MK, Thesing PC, Eddington ND et al. (2006) Return of chloroquine antimalarial efficacy in Malawi. New England Journal of Medicine 355, 1959-1966.
37. Lien TX, Tien NT, Chanpong GF et al. (2000) Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam. American Journal of Tropical Medicine and Hygiene 62, 301-309.
38. Lugada E, Levin J, Abang B et al. (2010) Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. Journal of Acquired Immune Deficiency Syndromes 55, 245-252.
39. Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K & Ashorn P (2010) Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. American Journal of Tropical Medicine and Hygiene 83, 1212-1220.
40. Malonza IM, Richardson BA, Kreiss JK, Bwayo JJ & Stewart GC (2003) The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial. AIDS 17, 113-118.
41. Martin SK, Oduola AM & Milhous WK (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235, 899-901.
42. Mayaud P, Grosskurth H, Changalucha J et al. (1995) Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bulletin of the World Health Organization 73, 621-630.
43. Mayaud P, Ka-Gina G, Cornelissen J et al. (1998) Validation of a WHO algorithm with risk assessment for the clinical management of vaginal discharge in Mwanza, Tanzania. Sexually Transmitted Infections 74(Suppl 1), S77-S84.
44. Mbaye A, Richardson K, Balajo B et al. (2006) A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Tropical Medicine and International Health 11, 992-1002.
45. Mccormick MC (1985) The contribution of low birthweight to infant mortality and childhood morbidity. New England Journal of Medicine 312, 82-90.
46. Mcdonald H, Brocklehurst P & Parsons J (2005) Antibiotics for treating bacterial vaginosis in pregnancy. The Cochrane Database of Systematic Reviews 1, CD000262.
47. Menendez C, D'alessandro U & Ter Kuile FO (2007) Reducing the burden of malaria in pregnancy by preventive strategies. The Lancet Infectious Diseases 7, 126-135.
48. Menendez C, Bardaji A, Sigauque B et al. (2008) A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE 3, e1934.
49. Menendez C, Bardaji A, Sigauque B et al. (2010) Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS ONE 5, e9438.
50. Mockenhaupt FP, Bedu-Addo G, Junge C, Hommerich L, Eggelte TA & Bienzle U (2007) Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrobial Agents and Chemotherapy 51, 332-334.
51. Msyamboza KP, Savage EJ, Kazembe PN et al. (2009) Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Tropical Medicine and International Health 14, 183-189.
52. Mullick S, Watson-Jones D, Beksinska M & Mabey D (2005) Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sexually Transmitted Infections 81, 294-302.
53. Mwai L, Ochong E, Abdirahman A et al. (2009) Chloroquine resistance before and after its withdrawal in Kenya. Malaria Journal 8, 106.
54. Nakornchai S & Konthiang P (2006) Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Tropica 100, 185-191.
55. Ndyomugyenyi R, Clarke Se, Hutchison Cl, Twesigomwe T, Hansen Ks & Magnussen P (2010) Efficacy of malaria prevention during pregnancy in low and unstable transmission: an individually randomized placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in Kabale district, south western Uganda. 59th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Atlanta, GA, USA.
56. Noedl H, Krudsood S, Chalermratana K et al. (2006) Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clinical Infectious Diseases 43, 1264-1271.
57. Noedl H, Krudsood S, Leowattana W et al. (2007) In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrobial Agents and Chemotherapy 51, 651-656.
58. Ohrt C, Willingmyre GD, Lee P, Knirsch C & Milhous W (2002) Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy 46, 2518-2524.
59. Oldfield EC III, Fessel WJ, Dunne MW et al. (1998) Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clinical Infectious Diseases 26, 611-619.
60. O'meara WP, Mangeni JN, Steketee R & Greenwood B (2010) Changes in the burden of malaria in sub-Saharan Africa. The Lancet Infectious Diseases 10, 545-555.
61. Osmond C & Barker DJ (2000) Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environmental Health Perspectives 108(Suppl 3), 545-553.
62. Pachot JI, Botham RP, Haegele KD & Hwang K (2003) Experimental estimation of the role of P-Glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model. Journal of Pharmacy and Pharmaceutical Sciences 6, 1-12.
63. Peeling R (2003) The Sexually Transmitted Diseases Diagnostics Initiative: Laboratory Based Evaluation of Rapid Syphilis Diagnostics. WHO, Geneva.
64. Peeling RW & Ye H (2004) Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bulletin of the World Health Organization 82, 439-446.
65. Peeling RW, Holmes KK, Mabey D & Ronald A (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sexually Transmitted Infections 82(Suppl 5), v1-v6.
66. Rahangdale L, Guerry S, Bauer HM et al. (2006) An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sexually Transmitted Diseases 33, 106-110.
67. Retsema J & Fu W (2001) Macrolides: structures and microbial targets. International Journal of Antimicrobial Agents 18(Suppl 1), 3-10.
68. Riedner G, Rusizoka M, Todd J et al. (2005) Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. New England Journal of Medicine 353, 1236-1244.
69. Rogerson SJ, Hviid L, Duffy PE, Leke RF & Taylor DW (2007) Malaria in pregnancy: pathogenesis and immunity. The Lancet Infectious Diseases 7, 105-117.
70. Sato NS, De Melo CS, Zerbini LC, Silveira EP, Fagundes LJ & Ueda M (2003) Assessment of the rapid test based on an immunochromatography technique for detecting anti-Treponema pallidum antibodies. Revista do Instituto de Medicina Tropical de Sao Paulo 45, 319-322.
71. Schlünzen F, Harms JM, Franceschi F et al. (2003) Structural basis for the antibiotic activity of ketolides and azalides. Structure 11, 329-338.
72. Shulman CE, Dorman EK, Cutts F et al. (1999) Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353, 632-636.
73. Sibai B, Dekker G & Kupferminc M (2005) Pre-eclampsia. Lancet 365, 785-799.
74. Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL & Breman JG (1996a) The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene 55, 33-41.
75. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL & Breman JG (1996b) Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. American Journal of Tropical Medicine and Hygiene 55, 50-56.
76. Steketee RW, Wirima JJ, Slutsker L et al. (1996c) Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. American Journal of Tropical Medicine and Hygiene 55, 24-32.
77. Steketee RW, Nahlen BL, Parise ME & Menendez C (2001) The burden of malaria in pregnancy in malaria-endemic areas. American Journal of Tropical Medicine and Hygiene 64, 28-35.
78. Sykes A, Hendriksen I, Mtove G et al. (2009) Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. Clinical Infectious Diseases 49, 1195-201.
79. Tagbor H, Bruce J, Agbo M, Greenwood B & Chandramohan D (2010) Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE 5, e14425.
80. Takechi M, Matsuo M, Ziba C et al. (2001) Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulphadoxine-pyremethamine and other antimalarial drugs in Malawian children. Tropical Medicine and International Health 6, 429-434.
81. Ter Kuile FO, Van Eijk AM & Filler SJ (2007) Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Journal of the American Medical Association 297, 2603-2616.
82. Thriemer K, Starzengruber P, Khan WA et al. (2010) Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial. Journal of Infectious Diseases 202, 392-398.
83. Van Broek Den NR, White SA, Goodall M et al. (2009) The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis. PLoS Medicine 6, e1000191.
84. Van Eijk AM, Hill J, Alegana VA et al. (2011) Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. The Lancet Infectious Diseases 11, 190-207.
85. Vuylsteke B, Laga M, Alary M et al. (1993) Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clinical Infectious Diseases 17, 82-88.
86. WHO (2001) Guidelines for the Management of Sexually Transmitted Infections. WHO/HIV-AIDS/2001.01. Geneva.
87. WHO (2003) The sexually transmitted disease initiative report. In: Special Program for Research and Training in Tropical Diseases. Diagnostics Evaluation Series, No. 1. 2003, Geneva.
88. WHO (2005) Sexually Transmitted and Other Reproductive Tract Infections: Guide to Essential Practice. Department of Reproductive Health and Research, WHO, Geneva.
89. WHO (2009) World Malaria Report 2009. WHO, Geneva.
90. WHO (2011) High risk groups: Malaria in pregnancy [Online], Geneva. Available at: . Accessed on January 27, 2011.
91. WHO Antenatal Care Trial Research Group (2002) WHO Antenatal Care Randomized Trial: Manual for the Implementation of the New Model. WHO, Department of Reproductive Health and Research, Geneva.
92. WHO & Special Programme for Research and Training in Tropical Diseases (2006) The Use of Rapid Syphilis Tests. WHO, Geneva.
93. Wickaramsuriya GAW (1937) Clinical Features of Malaria in Pregnancy. Malaria and Ankylostomiasis in Pregnant Women. Oxford University Press, London.
94. Zhou P, Qian Y, Xu J, Gu Z & Liao K (2007) Occurrence of congenital syphilis after maternal treatment with azithromycin during pregnancy. Sexually Transmitted Diseases 34, 472-474.